Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02865928Phase 4Terminated
Phase 4, randomised, double-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Northwell Health. Primary endpoint: Postoperative Opioid Requirements. Started Sep 2017; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02865928.